spacer
home > ict > spring 2008 > solid supply
PUBLICATIONS
International Clinical Trials

Solid Supply

Chris Tierney at DHL Exel Supply Chain considers the need for consolidation of global clinical trial supply networks alongside the twin drivers of cost reduction and service enhancement within this increasingly competitive industry

In the last decade, there has been considerable consolidation within the pharmaceutical industry across the globe. This has, in the main, been precipitated by an overall theme of rationalisation, whereby mergers and acquisitions have reduced the number of large and mid-sized pharmaceutical companies with a pharmaceutical development focus. At the same time, the geographic scope and the scale of clinical studies has enjoyed a marked increase, with the pursuit of patient populations leading sponsors to emerging markets such as the Far East, Middle East and South America.

The environment in which todayís organisations operate has been characterised by a series of conflicting demands driving a focus on increasing the value of every R&D dollar invested. This is manifested as globalisation, a renewed vigour on cost reduction within R&D budgets and competition for target principal investigators and their patient populations.

READING TRENDS

For the supply chain, the impact of this shift is many-fold. The acquisition trend has led to a raft of varied products, many of which have become, or are heading towards, obsolescence. Companies are increasingly operating with multiple systems and from multiple facilities (both owned and third party) across the world. The result is a lack of visibility in terms of where products are at any given time, and a need to analyse the delivery of clinical supplies to investigators in order to avoid duplication of cost and resources.

Consequently, the more successful companies have, or are undergoing, a strategic business evaluation that takes a fresh look at the existing clinical trials logistics network and provides a proposition that, in the main, moves away from the legacy affiliate networks and introduces a strategic redesign that enables the creation of a supply chain for 2012 and beyond. This will allow the most agile organisations to capitalise quickly on accessing a wide range of diverse patient populations and focusing recruitment on lower cost geographies (at the expense of the more mature Western populations).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Tierney graduated in 1995 with a BSc in Medical Biochemistry and shortly after joined Exelís international management training scheme. He has worked in operations, strategic marketing and product development. In 2003, Chris completed his MBA. Chrisís current role is Business Development Manager for DHL Healthcare, and he has responsibility for global sales and the strategic development of the clinical trials logistics offerings
spacer
Chris Tierney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo adds Kuala Lumpur and Ahmedabad to its cargo flight network.

The fastest growing global air cargo brand Turkish Cargo continues to expand its cargo flight network. The successful air cargo carrier has added Malaysian capital Kuala Lumpur (KUL) and the western Indian city of Ahmedabad (AMD) among the destinations to which it performs direct cargo flights.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In todayís ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement